Cormedix Q3 EPS $(0.19) Misses $(0.10) Estimate, Sales $54.519M Beat $53.227M Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.10) by 90 percent. This is a 133.33 percent decrease over earnings of $0.57 per share from the
Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.10) by 90 percent. This is a 133.33 percent decrease over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $54.519 million which beat the analyst consensus estimate of $53.227 million by 2.43 percent. This is a 47.71 percent decrease over sales of $104.270 million the same period last year.